09/21/2020 12:00 AM EDT
Source: European Union, European Centre for Disease Prevention and Control (ECDC). Published: 9/21/2020. The aim of this 14-page Threat Assessment Brief is to elucidate the characteristics and frequency of confirmed SARS-CoV-2 reinfection in the literature, to summarize the findings about SARS-CoV-2 infection and antibody development, and to consider several questions about reinfection and transmission. (PDF)
09/21/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 9/21/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the KimForest SARS-CoV-2 Detection Kit v1. The KimForest SARS-CoV-2 Detection Kit v1 is authorized for use with respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider. (PDF)
09/15/2020 12:00 AM EDT
Source: European Union, European Centre for Disease Prevention and Control (ECDC). Published: 9/15/2020. This 22-page document outlines strategies and objectives for sustainable SARS-CoV-2 testing of populations to achieve specific public health objectives in various epidemiological situations. General population-wide testing, as well as targeted testing of individuals, or specific populations related to particular settings, are presented on the basis of country experiences and information collected from scientific literature. (PDF)
09/01/2020 12:00 AM EDT
Source: World Health Organization, Regional Office for Europe. Published: 9/2020. This 19-page report summarizes the findings of the rapid expert consultation on environmental surveillance of SARS-CoV-2 in wastewater that was organized by the WHO European Centre for Environment and Health on July 23, 2020, in a virtual format. It aimed to facilitate a rapid exchange of current knowledge, experience, and practices among countries that are in the forefront of research and environmental surveillance of SARS-CoV-2 in wastewater. (PDF)
09/01/2020 12:00 AM EDT
Source: RAND Corporation. Published: 9/2020. The authors of this 16-page report examine liability and compensation issues as they relate to the future distribution and administration of the COVID-19 vaccine. They provide a brief history of how the U.S. government has addressed liability and compensation concerns in previous public health threats — specifically by providing liability immunity to manufacturers and distributors of vaccines should lawsuits arise as the result of serious side effects, as well as by setting up compensation systems that provide some, but not all, benefits of traditional tort litigation. (PDF)
09/01/2020 12:00 AM EDT
Source: RAND Corporation. Published: 9/2020. This report uses the COVID-19 Air Traffic Visualization (CAT-V) tool to estimate when COVID-19 transmission via commercial air travel began to rapidly accelerate throughout the world. It estimates the global spread of COVID-19 by international air passengers prior to the March 11, 2020, declaration by the World Health Organization (WHO) that the world was officially experiencing a pandemic. (Text)
09/01/2020 12:00 AM EDT
Source: RAND Corporation. Published: 9/2020. This report uses the COVID-19 Air Traffic Visualization (CAT-V) tool to quantify the potential vectors of COVID-19 transmission to countries in the U.S. Africa Command (AFRICOM) area of responsibility (AOR), which encompasses every country in Africa except Egypt. (Text)
09/01/2020 12:00 AM EDT
Source: RAND Corporation. Published: 9/2020. The authors of this 20-page report assess five approaches to screening for symptoms of COVID-19 at the workplace: no screening, verbal screening, screening using a paper form or app, verbal screening plus a temperature check at the workplace, and screening using a paper form or app plus a temperature check at the workplace. They rate each approach on five criteria: likelihood of detecting infection, helping employees feel safer, safety of the screening interaction, feasibility, and privacy. (PDF)
06/01/2020 12:00 AM EDT
Source: RAND Corporation. Published: 6/2020. Using the COVID-19 Air Traffic Visualization (CAT-V) tool, this report estimates the daily rate of COVID-19 virus transmission via air travel from China. By January 31, 2020, passengers from China were likely exporting at least 1.5 cases of COVID-19 globally per day. (Text)
06/01/2020 12:00 AM EDT
Source: RAND Corporation. Published: 6/2020. This report uses the COVID-19 Air Traffic Visualization (CAT-V) tool to quantify the potential COVID-19 transmission vectors to the United Arab Emirates (UAE) and other Gulf Cooperation Council (GCC) countries. The analysis in this report is based on infection rates in other nations and the travel levels from those nations to the GCC countries between late January and late February 2020. (Text)
06/01/2020 12:00 AM EDT
Source: RAND Corporation. Published: 6/2020. This report quantifies potential vectors of virus transmission to the United States as a result of commercial air travel. Understanding the COVID-19 propagation patterns, regionally and globally, will help policymakers mitigate the resulting threats to public health. The COVID-19 Air Traffic Visualization (CAT-V) tool combines case data from Johns Hopkins University with detailed air travel data from the International Air Transport Association. (Text)
06/01/2020 12:00 AM EDT
Source: RAND Corporation. Published: 6/2020. This report uses the COVID-19 Air Traffic Visualization (CAT-V) tool to estimate the likely number of COVID-19 infections in China in early 2020. It presents strong evidence that China's reported COVID-19 caseload was undercounted by a factor of nearly 40. (Text)
.png)
No hay comentarios:
Publicar un comentario